These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15595191)

  • 1. [Heterozygotic familial hypercholesterolemia: argument for early treatment].
    Rosenburg D
    Arch Pediatr; 2004 Nov; 11(11):1410-1. PubMed ID: 15595191
    [No Abstract]   [Full Text] [Related]  

  • 2. Premature cardiovascular disease in young women with heterozygous familial hypercholesterolemia.
    van der Graaf A; Hutten BA; Kastelein JJ; Vissers MN
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):345-51. PubMed ID: 16716095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A First-in-Class Drug, Lomitapide, Tailored to Patients with Homozygous Familial Hypercholesterolemia is Just about Meeting with Good News to Them.
    Yoshida H
    J Atheroscler Thromb; 2017 Apr; 24(4):390-392. PubMed ID: 28239069
    [No Abstract]   [Full Text] [Related]  

  • 4. [Familial hypercholesterolemia].
    Widhalm K
    Dtsch Med Wochenschr; 2000 Jan; 125(4):99. PubMed ID: 10733301
    [No Abstract]   [Full Text] [Related]  

  • 5. Familial hypercholesterolemia: current treatment and advances in management.
    Huijgen R; Vissers MN; Defesche JC; Lansberg PJ; Kastelein JJ; Hutten BA
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):567-81. PubMed ID: 18402545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Familial hypercholesterolemia: treatable receptor disease].
    Kovanen PT; Tikkanen MJ; Pyörälä K
    Duodecim; 1992; 108(15):1305-17. PubMed ID: 1366090
    [No Abstract]   [Full Text] [Related]  

  • 7. Mipomersen, an antisense oligonucleotide to apolipoprotein B-100, reduces lipoprotein(a) in various populations with hypercholesterolemia: results of 4 phase III trials.
    Santos RD; Raal FJ; Catapano AL; Witztum JL; Steinhagen-Thiessen E; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):689-99. PubMed ID: 25614280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Coronary artery bypass graft in adolescent suffering from homozygous familial hypercholesterolemia resistant to probucol therapy].
    Ayegnon KG; Morcos KK; Yangni-Angate KH; Ahmed-Nasr M
    Mali Med; 2009; 24(2):62-4. PubMed ID: 19666374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Should children with familial hypercholesterolemia be treated with statins?].
    Tonstad S
    Lakartidningen; 2004 Oct; 101(44):3406. PubMed ID: 15560654
    [No Abstract]   [Full Text] [Related]  

  • 10. Preventing early cardiovascular death in patients with familial hypercholesterolemia.
    Repas TB; Tanner JR
    J Am Osteopath Assoc; 2014 Feb; 114(2):99-108. PubMed ID: 24481802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A patient with the homozygote form of familial hypercholesterolemia].
    Gorter JW; Schilte PP; Lansberg PJ; Kastelein JJ; Bakker HD
    Tijdschr Kindergeneeskd; 1991 Jun; 59(3):88-91. PubMed ID: 1862513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a problem with ezetimibe or just ENHANCEd hype?
    Whayne TF
    Angiology; 2008 Dec-2009 Jan; 59(6):661-3. PubMed ID: 18796445
    [No Abstract]   [Full Text] [Related]  

  • 13. [Is statin treatment for children safe and effective?].
    Marchetti F; Cannioto Z
    Recenti Prog Med; 2008 Dec; 99(12):599-601. PubMed ID: 19388217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Familial hypercholesterolemia].
    Heinzl S
    Med Monatsschr Pharm; 1987 Dec; 10(12):381-7. PubMed ID: 3325786
    [No Abstract]   [Full Text] [Related]  

  • 15. In brief: Zetia and Vytorin: the ENHANCE study.
    Med Lett Drugs Ther; 2008 Jan; 50(1278):5. PubMed ID: 18219263
    [No Abstract]   [Full Text] [Related]  

  • 16. New pharmacologic treatments for familial hypercholesterolemia.
    McDonough A; Matura LA; Carroll D
    Nurs Womens Health; 2013 Oct; 17(5):443-7. PubMed ID: 24138664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel pharmacological treatments for children and adolescents with heterozygous familial hypercholesterolemia.
    Wiegman A; Hutten BA
    Expert Rev Clin Pharmacol; 2017 Sep; 10(9):919-921. PubMed ID: 28756723
    [No Abstract]   [Full Text] [Related]  

  • 18. For patients who inherit homozygous familial hypercholesterolemia, 2 new treatments available.
    Morrow T
    Manag Care; 2013 Mar; 22(3):47-8. PubMed ID: 23610808
    [No Abstract]   [Full Text] [Related]  

  • 19. [Up to date lipid lowering treatment].
    Paragh G; Karádi I
    Orv Hetil; 2016 Jul; 157(31):1219-23. PubMed ID: 27476517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INTERIM guidelines for the diagnosis and management of familial hypercholesterolaemia.
    Sullivan DR; Hamilton-Craig I; van Bockxmeer F; Watts GF;
    Heart Lung Circ; 2012 Mar; 21(3):159-62. PubMed ID: 22364837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.